(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/10/07 | 日証協 | 681,300株 | -10.95% | 59,293株 | +12.72% | 474,323株 | -10.05% | 10,500株 | -41.36% |
2016/09/30 | 日証協 | 765,100株 | -9.35% | 52,600株 | +497.73% | 527,323株 | -6.24% | 17,905株 | +40.87% |
2016/09/23 | 日証協 | 844,000株 | -4.51% | 8,800株 | -88.06% | 562,408株 | -4.01% | 12,710株 | -62.18% |
2016/09/16 | 日証協 | 883,900株 | -2.96% | 73,700株 | -48.46% | 585,898株 | -5.16% | 33,610株 | -58.15% |
2016/09/09 | 日証協 | 910,900株 | +11.85% | 143,000株 | +17.22% | 617,788株 | +9.45% | 80,310株 | -4.89% |
2016/09/02 | 日証協 | 814,408株 | +1.08% | 121,992株 | +85.38% | 564,469株 | +6.09% | 84,439株 | +217.12% |
2016/08/26 | 日証協 | 805,708株 | +8% | 65,808株 | +112.98% | 532,075株 | +6.98% | 26,627株 | -1.1% |
2016/08/19 | 日証協 | 746,009株 | -0.8% | 30,899株 | -49.76% | 497,347株 | -3.58% | 26,922株 | +41.46% |
2016/08/12 | 日証協 | 752,009株 | +3.52% | 61,501株 | -63.82% | 515,826株 | -1.32% | 19,031株 | -86.53% |
2016/08/05 | 日証協 | 726,408株 | +24.32% | 170,001株 | +14.09% | 522,704株 | +36.05% | 141,311株 | +43.27% |
2016/07/29 | 日証協 | 584,308株 | +1.79% | 149,001株 | +136.89% | 384,194株 | -5.27% | 98,633株 | +125.63% |
2016/07/22 | 日証協 | 574,008株 | +8.4% | 62,900株 | -18.21% | 405,569株 | +9.1% | 43,715株 | -33.1% |
2016/07/15 | 日証協 | 529,508株 | -7.59% | 76,900株 | -33.25% | 371,744株 | -6.32% | 65,340株 | +165.39% |
2016/07/08 | 日証協 | 573,000株 | +15.87% | 115,199株 | +24.16% | 396,829株 | +10.97% | 24,620株 | -67.06% |
2016/07/01 | 日証協 | 494,508株 | -1.38% | 92,785株 | -30.48% | 357,599株 | +0.93% | 74,746株 | +33.45% |
2016/06/24 | 日証協 | 501,408株 | +10.64% | 133,467株 | -37.89% | 354,299株 | +2.98% | 56,010株 | -69.79% |
2016/06/17 | 日証協 | 453,208株 | +27.91% | 214,900株 | +48.41% | 344,061株 | +1.84% | 185,418株 | +10.14% |
2016/06/10 | 日証協 | 354,308株 | +0.25% | 144,800株 | +440.3% | 337,851株 | +22.08% | 168,341株 | +410.12% |
2016/06/03 | 日証協 | 353,408株 | +8.44% | 26,800株 | -59.94% | 276,741株 | +12.8% | 33,000株 | -40.76% |
※株式分割は考慮していませんのでご注意ください。
Page Top